KSE - Delayed Quote
KRW
Chong Kun Dang Holdings Corp. (001630.KS)
35,250.00
+200.00
(+0.57%)
At close: 3:30:30 PM GMT+9
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in KRW.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Mr. Hee-Nam Choi
|
CEO, President & Chairman | -- | -- | 1960 |
|
Mr. KiSeong Lee
|
Financial Director | -- | -- | 1968 |
Chong Kun Dang Holdings Corp.
8, Chungjeong-ro
Seodaemun-gu
Seoul
South Korea
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 35
Description
Chong Kun Dang Holdings Corp. manufactures and distributes pharmaceutical products in South Korea and internationally. Chong Kun Dang Holdings Corp. was founded in 1941 and is based in Seoul, South Korea.
Corporate Governance
Chong Kun Dang Holdings Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of
Institutional Shareholder Services (ISS)
Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
March 30, 2026 at 12:00 AM UTC
Ex-Dividend Date
